Novo Nordisk Should Have Studied Insulin Icodec Twice-Weekly Dosing, US Panel Says

 
• By Sue Sutter
  
Complexity
Novo Nordisk said a twice-weekly insulin icodec regimen would have created too much complexity. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers